CLINICAL_TRIALS
trial_result
· 2015-09-07
Clinical Trial Update: Single-Dose Study of a New Formulation of BIIB061 [Phase 1]
Summary
Phase 1 single-dose study of a new formulation of BIIB061 conducted in multiple sclerosis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biogen | Conditions: Multiple Sclerosis | Phase 1 | Status: COMPLETED